Specialized Rehabilitation & Pain Care in Gangnam, Seoul · Dedicated International Concierge
Medical Guide
Understanding PRP Therapy: How Platelets Support Healing
What platelets really do at an injury site, why concentrating them is the idea behind PRP therapy, and why no two PRP preparations are quite alike.
Schedule a ConsultationUnderstanding PRP Therapy: How Platelets Support Healing
Medically reviewed by Dr. Kim DaeHwan, Director, Well Rehabilitation Clinic; Specialist in Rehabilitation Medicine
PRP therapy rests on a single biological observation: platelets do considerably more at an injury site than stop bleeding, and much of what they do is chemical signaling that summons the cells responsible for repair. The reasoning behind the treatment is that if those signals are useful, a preparation containing more of them might be useful too. This article stays with that reasoning — the biology underneath the idea — rather than with the appointment itself.
Platelets are messengers as well as plugs
Most people learn one job for platelets in school biology, which is to clump together and stop blood escaping. That job is real, and it is the smaller half of the story.
StatPearls, a peer-reviewed clinical reference hosted on the US National Library of Medicine's Bookshelf, describes what happens immediately after tissue is injured. Blood vessels narrow, platelets gather, and the two coagulation pathways engage. Adenosine diphosphate released at the scene causes platelets to clump and sets thrombosis going. The narrowing of the vessels is short-lived and is followed by widening, which lets white cells and further platelets into the area.
So within minutes of an injury the platelet population at the site is doing two things at once: physically sealing, and chemically summoning. It is the second activity that matters for understanding this treatment.
What the summoning actually consists of
The signaling is specific, and naming the molecules makes the logic easier to follow.
StatPearls describes serotonin and histamine released from platelets increasing the permeability of surrounding cells, which is what allows other cells to move into the area at all. It describes platelet-derived growth factor attracting fibroblasts, and platelet-derived growth factor together with transforming growth factor driving those fibroblasts to divide. Fibroblasts are the cells that synthesize collagen, which is the structural protein most repair depends on.
Meanwhile a scaffold is being built. Neutrophils, monocytes and endothelial cells adhere to a fibrin mesh generated from the platelets, and the neutrophils consume debris and bacteria, clearing the site so that construction can begin.
Read that sequence back and a pattern emerges: the platelet population is acting as a recruitment office. It increases access, calls in the cells that build, tells them to multiply, and provides the surface they attach to. Nothing in that description says the platelets themselves do the rebuilding.
Why anyone concentrates them
The therapeutic idea follows directly, and it is worth stating in its properly hedged form.
If signaling from platelets is what initiates the repair response, then delivering a preparation containing an increased proportion of platelets to a site that is healing slowly might amplify that early signal. That is the hypothesis. It is a reasonable hypothesis, it has motivated a large amount of research, and it is not the same thing as a demonstrated outcome.
StatPearls describes how such preparations are made in general terms: a blood sample is processed by centrifugation, in a single-spin or double-spin protocol, and the platelet level in the resulting material is typically several times that of whole blood. Calcium chloride or a thrombin preparation may be used as an activator.
Well Rehabilitation Clinic in Gangnam-gu, Seoul describes its own PRP therapy in matching terms: a regenerative treatment using a concentrated preparation of the patient's platelets, prepared and then applied to the targeted treatment area. The clinic states that its PRP is prepared using a Pervice PRP system, and lists treatment areas including the shoulder, elbow, wrist, ankle, foot and knee joint.
Why "PRP" names a category, not a product
This is the detail that most changes how a patient should read claims about the treatment, and it follows from how the preparations are made.
StatPearls classifies these preparations into leukocyte-rich and leukocyte-poor types, depending on whether white blood cells are retained along with the platelets. The distinction is not cosmetic: leukocyte-rich preparations are described as more pro-inflammatory, and the reference reports that leukocyte-poor preparations perform better in osteoarthritis. It also notes that preparation methods vary so widely across products and protocols that no universal classification has been agreed.
That variation has a direct consequence for reading research. When one trial reports benefit and another does not, part of the disagreement may be that the two trials were studying materially different substances. StatPearls names differences in preparation method as one of the reasons outcomes across studies are heterogeneous.
The practical version of this for a patient is short: "I had PRP" describes a family of treatments rather than a single one, and it is reasonable to ask a clinician what is being prepared and by what method.
What the treatment is not designed to do
Precision protects patients here, so the limits deserve their own section.
Concentrating platelets is a way of influencing a signaling environment. It is not a way of installing new structural tissue, and no serious account of this treatment claims otherwise. The published literature discusses changes in pain and function; it does not describe the reversal of established joint damage.
StatPearls is also direct about regulatory and evidential standing. It states that most biologic therapies, platelet-rich plasma among them, remain investigational or are used off-label, with viscosupplementation for knee osteoarthritis being the one approach in this category it describes as carrying clearance for a specific indication.
Holding both halves at once is the honest position. The biology behind the treatment is sound biology. Whether amplifying that biology produces a clinical difference in a given condition is a separate question, answered separately for each condition, and answered variably.
Why tissue type changes the conversation
The same preparation is not facing the same task in every part of the body, which is another reason results differ.
StatPearls, in its chapter on tendinosis, describes tendon as a tissue that heals slowly because of its limited blood supply, with most overuse problems taking three to six months to recover even when managed well. Its account of degenerative tendon change is of disorganized collagen and abnormal vessel growth rather than of ordinary inflammation, which is why treatments aimed at inflammation often disappoint there.
Its chapter on plantar fasciitis makes a related point about the heel: despite the name, the condition is characterized by an absence of inflammatory cells, and the tissue shows granulation, micro-tears and collagen disarray on histology. The chapter lists autologous platelet-rich plasma injection among the options considered when conservative measures have not worked, and specifies that such options should be combined with continuing conservative care.
The shoulder illustrates the same point from a different angle. MedlinePlus, describing rotator cuff injuries, notes that these problems arise both from a single injury and from wear accumulating over years, that treatment usually begins with rest, activity modification and physical therapy, and that diagnosis rests on history, examination and imaging. A treatment aimed at the healing response is therefore entering a situation that has usually been building for a long time, in a structure that is being asked to keep working throughout.
A treatment aimed at the healing response lands differently in a tendon, in a fascia and in a joint, and the evidence for each has to be read on its own.
Where it sits relative to everything else you could do
Sequencing is part of understanding a treatment, not an afterthought.
StatPearls places conservative management first across these conditions: relative rest, activity modification, therapist-guided loading exercise, correction of biomechanics, and time. Injections of any kind enter the discussion when that approach has had a fair run and has not resolved the problem, and even then the advice is to continue the conservative work alongside.
MedlinePlus, the National Library of Medicine's patient-education service, frames the wider context the same way. Rehabilitation, on its account, is care aimed at recovering or preserving the abilities daily life requires, normally run by a team that settles the goals and the plan jointly, and treatment for pain is listed as one component among many. An injection belongs inside such a plan rather than instead of one.
Well Rehabilitation Clinic has focused on musculoskeletal pain treatment and rehabilitation after surgery since it opened in 2019, and offers PRP therapy alongside manual therapy, focused and radial shock wave therapy, and postural and body alignment correction. The full service list appears on the clinic's about us page.
What a first conversation should establish
Understanding the mechanism converts into a short list of things worth settling before anything is scheduled.
What is the working diagnosis, and what tissue is involved? What does the evidence look like for this treatment in that specific tissue, as opposed to in general? What preparation method is used, and is it leukocyte-rich or leukocyte-poor? What conservative measures have been tried, for how long, and what would continuing them add? And what would count as improvement, observed how, and by when would you expect to reassess?
None of those questions can be settled from a web page, and none of them should be. They belong in a room with a clinician who has examined the area in question and can put the mechanism described here against what is actually going on in your shoulder or your heel. That conversation can be started through the clinic's contact page.
The Bottom Line
- Platelets both seal an injury and signal to it, releasing factors that draw in fibroblasts and drive them to divide so that collagen can be laid down.
- The idea behind PRP therapy is to amplify that early signal; that is a hypothesis about a mechanism, not a demonstrated result.
- PRP names a family of preparations rather than one product, and leukocyte-rich and leukocyte-poor versions behave differently.
- Tendon, fascia and joint present different healing problems, so evidence has to be read condition by condition rather than for the category.
- StatPearls describes most biologic therapies, PRP included, as investigational or used off-label, and places them after conservative care rather than before it.
Frequently Asked Questions
What do platelets actually do besides clotting?
They signal. StatPearls describes platelet-released serotonin and histamine increasing cellular permeability, platelet-derived growth factor attracting fibroblasts, and growth factors driving those fibroblasts to divide so that collagen is produced. Platelets also generate the fibrin scaffold other repair cells adhere to.
How is a platelet-rich preparation made?
By centrifugation of a blood sample in a single-spin or double-spin protocol, producing material whose platelet level is typically several times that of whole blood. An activator such as calcium chloride or a thrombin preparation may be used. Well Rehabilitation Clinic states that it prepares PRP using a Pervice PRP system.
Why do studies of PRP disagree with each other?
Partly because they are not all studying the same material. StatPearls notes that preparation methods vary so widely that no universal classification exists, and names those differences as a reason outcomes across studies are heterogeneous. Treatment site and the rehabilitation that follows also shift results.
What is the difference between leukocyte-rich and leukocyte-poor PRP?
Whether white blood cells are retained alongside the platelets. StatPearls describes leukocyte-rich preparations as more pro-inflammatory and reports that leukocyte-poor preparations perform better in osteoarthritis. It is a fair question to ask a clinician.
Does PRP work the same way everywhere in the body?
No. StatPearls describes tendon as healing slowly because of limited blood supply, and describes plantar fascia problems as degenerative rather than inflammatory. Different tissues present different problems, so the evidence has to be judged for the specific site.
Is this treatment approved?
StatPearls states that most biologic therapies, platelet-rich plasma included, remain investigational or are used off-label. Within the same category it describes viscosupplementation for knee osteoarthritis as holding clearance for that specific indication.
Should I try other things first?
That is the sequence the literature describes. Relative rest, activity modification, guided loading exercise and biomechanical correction come first, and injections enter the discussion when those have had a fair run. Even then, the advice is to continue conservative care alongside.
This article is for general informational purposes and does not constitute individualized medical advice. It is not a self-diagnosis tool. Rehabilitation candidacy, technique, and expected outcomes can only be determined through a consultation with a qualified rehabilitation physician.
More Articles
Continue reading educational guides from Well Rehabilitation Clinic.
Chronic Tendon Pain Explained: When ESWT May Help
What chronic tendon pain is, why tendons are slow to settle, what conservative care comes first, and where extracorporeal shock wave therapy fits in the plan.
Learn More
Is Manual Therapy Painful? What a Session Feels Like
Is manual therapy painful? What hands-on treatment usually feels like, how the intensity is set, and what to tell your clinician before and during a session.
Learn More
When Musculoskeletal Pain Needs a Specialist Assessment
The patient-side thresholds that move a musculoskeletal problem from self-care to a rehabilitation medicine assessment, and how to judge if yours apply.
Learn More